Aspen Pharmacare Holdings Limited

As of December 31, 2025, Aspen Pharmacare Holdings plc carries a market capitalization of 2.98B, placing it among publicly traded companies globally. Its enterprise value stands at 4.64B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Aspen Pharmacare Holdings plc's next confirmed earnings release is scheduled for March 11, 2027.

As of December 31, 2025, Aspen Pharmacare Holdings plc has 457.76M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Aspen Pharmacare Holdings plc maintains a current ratio of 3.64, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on August 14, 2026, Aspen Pharmacare Holdings plc's stock has gained approximately 22.70% over the past 52 weeks. The 50-day moving average sits at 9.70, while the 200-day moving average is 14.73.

As of December 31, 2025, Aspen Pharmacare Holdings plc holds 339.41M in cash and equivalents against 1.99B in total debt, resulting in a net debt position of 1.65B. Total book value stands at 4.90B, with working capital of 2.51B providing operational flexibility.

Aspen Pharmacare Holdings plc's most recent stock split took place on October 6, 2008.